Solventum Corporation (SOLV)
(Delayed Data from NYSE)
$54.13 USD
-2.03 (-3.61%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $54.01 -0.12 (-0.22%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SOLV 54.13 -2.03(-3.61%)
Will SOLV be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for SOLV based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SOLV
Solventum: 3 Reasons Why This Healthcare Spinoff Is A Sell
Wells Fargo Sticks to Their Hold Rating for Solventum Corporation (SOLV)
Ready to Rally: Ride These 3 Stocks to Dow 50K
Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"
Solventum says its neutral toward TRC mini tender offer